Picture of Drax logo

DRX Drax News Story

0.000.00%
gb flag iconLast trade - 00:00
UtilitiesAdventurousMid CapSuper Stock

REG - Drax Group Plc - Pricing of offering of Senior Secured Notes

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240418:nRSR2275La&default-theme=true

RNS Number : 2275L  Drax Group PLC  18 April 2024

18 April 2024

 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO AUSTRALIA, CANADA OR
JAPAN OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES OF SECURITIES
WOULD BE PROHIBITED BY APPLICABLE LAW. PLEASE SEE THE IMPORTANT NOTICES AT THE
END OF THIS RELEASE.

Drax Group plc

(LSE: DRX)

Pricing of offering of five-year Senior Secured Notes

Drax Group plc ("Drax") today announced that its indirect wholly owned
subsidiary, Drax Finco plc (the "Issuer"), priced its offering (the
"Offering") of euro denominated five-year senior secured notes (the "Notes")
in an aggregate principal amount of €350 million.

The Notes will bear interest at an interest rate of 5.875% per cent. per annum
and will be issued at 100 per cent. of their nominal value. The Notes will
extend the Group's average debt maturity profile.

Drax intend to use the gross proceeds of the Offering (i) for general
corporate purposes, which may include the repayment of indebtedness, and (ii)
to pay estimated fees and expenses of the Offering, including Initial
Purchasers' fees and commissions, professional fees and other associated
transaction costs.

Enquiries:

Drax Investor Relations: Mark Strafford

mark.strafford@drax.com

+44 (0) 7730 763 949

 

Media:

Drax External Communications: Andy Low

andrew.low@drax.com

+44 (0) 7841 068 415

 

Website: www.drax.com

Cautionary Statement

This release is being issued pursuant to Rule 135c under the U.S. Securities
Act of 1933, as amended (the "Securities Act") and is for information purposes
only and does not constitute a prospectus or any offer to sell or the
solicitation of an offer to buy any security in the United States of America
or in any other jurisdiction. The Notes have not been and will not be
registered under the Securities Act, and may not be offered or sold in the
United States of America absent registration or an exemption from registration
under the Securities Act. The Notes and related guarantees were offered in a
private offering exempt from the registration requirements of the Securities
Act and were accordingly offered only to non-U.S. persons, in offshore
transactions, as defined in and in reliance on Regulation S under the
Securities Act. No indebtedness incurred in connection with any other
financing transactions will be registered under the Securities Act.

This communication is directed only at persons who (i) have professional
experience in matters relating to investments falling within Article 19(5) of
the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005
as amended (the "Order"), (ii) are persons falling within Article 49(2)(a) to
(d) ("high net worth companies, unincorporated associations, etc.") of the
Order, (iii) are persons who are outside the United Kingdom, or (iv) are
persons to whom an invitation or inducement to engage in investment activity
(within the meaning of section 21 of the Financial Services and Markets Act
2000) in connection with the issue or sale of any notes may otherwise lawfully
be communicated or caused to be communicated (all such persons together being
referred to as "relevant persons").

Any investment activity to which this communication relates will only be
available to, and will only be engaged in with, relevant persons. Any person
who is not a relevant person should not act or rely on this document or any of
its contents.

This announcement is not a public offering in the Grand Duchy of Luxembourg or
an offer of securities to the public under Regulation (EU) 2017/1129, and any
amendments thereto.

The Notes are not intended to be offered, sold or otherwise made available to
and should not be offered, sold or otherwise made available to any retail
investor in the European Economic Area (the "EEA") or in the United Kingdom
(the "UK"). For these purposes, a retail investor means a person who is one
(or more) of: (i) a retail client as defined in point (11) of Article 4(1) of
Article 4(1) of MiFID II; (ii) a customer within the meaning of the Insurance
Distribution Directive), where that customer would not qualify as a
professional client as defined in point (10) of Article 4(1) of MiFID II; or
(iii) not a qualified investor as defined in Regulation (EU) 2017/1129 (as
amended, the "Prospectus Regulation"). Consequently no key information
document required by Regulation (EU) No 1286/2014 (as amended, the "PRIIPs
Regulation") for offering or selling the Notes or otherwise making them
available to retail investors in the EEA or in the UK will be prepared.
Offering or selling the Notes or otherwise making them available to any retail
investor in the EEA or in the UK may be unlawful under the PRIIPs Regulation.
Any offer of Notes in any Member State of the EEA or in the UK will be made
pursuant to an exemption under the Prospectus Regulation from the requirement
to publish a prospectus for offers of Notes.

The Manufacturer target market (MiFID II product governance) is eligible
counterparties and professional clients only (all distribution channels).

In connection with any issuance of the Notes, a stabilising manager (or
person(s) acting on behalf of such stabilising manager) may over-allot Notes
or effect transactions with a view to supporting the market price of the Notes
at a level higher than that which might otherwise prevail. However,
stabilisation may not necessarily occur. Any stabilisation action may begin on
or after the date on which adequate public disclosure of the terms of the
offer of the Notes is made and, if begun, may be ended at any time, but it
must end no later than 30 days after the date on which the issuer received the
proceeds of the issue, or no later than 60 days after the date of the
allotment of the Notes, whichever is earlier. Any stabilisation action or
over-allotment must be conducted by the stabilising manager (or person(s)
acting on behalf of the stabilising manager) in accordance with all applicable
laws and rules.

Forward Looking Statements

This release includes forward-looking statements within the meaning of the
securities laws of certain applicable jurisdictions. These forward-looking
statements can be identified by the use of forward-looking terminology,
including, but not limited to, terms such as "aim", "anticipate", "assume",
"believe", "continue", "could", "estimate", "expect", "forecast", "guidance",
"intend", "may", "outlook", "plan", "predict", "project", "should", "will" or
"would" or, in each case, their negative, or other variations or comparable
terminology. These forward-looking statements include, but are not limited to,
all statements other than statements of historical facts and include
statements regarding Drax's intentions, beliefs or current expectations
concerning, among other things, Drax's future financial conditions and
performance, results of operations and liquidity, strategy, plans, objectives,
prospects, growth, goals and targets, future developments in the markets in
which Drax participate or are seeking to participate, and anticipated
regulatory changes in the industry in which Drax operate. By their nature,
forward-looking statements involve known and unknown risks, uncertainties and
other factors because they relate to events and depend on circumstances that
may or may not occur in the future. Readers are cautioned that forward-looking
statements are not guarantees of future performance and are based on numerous
assumptions. Given these risks and uncertainties, readers should not rely on
forward looking statements as a prediction of actual results.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IODGPUBACUPCGAR

Recent news on Drax

See all news